RoosterBio and Qkine have entered a distribution agreement to provide U.S. customers with a single-source platform for c...
Catalent and Nanoscope Therapeutics have expanded their partnership to support late-phase clinical development and comme...
FibroBiologics has completed manufacturing of the third batch of CYWC628 drug product for its ongoing Phase 1/2 clinical...
Matica Biotechnology has entered a partnership with VaxDome to support development of antigen-agnostic antiviral-vaccine...
Brii Biosciences has reported topline end-of-treatment data from its ongoing Phase 2b ENRICH and ENHANCE studies evaluat...
Ascletis Pharma has submitted two Investigational New Drug applications to the U.S. FDA for obesity treatment candidates...
As cell and gene therapies progress from promising research to commercial reality, manufacturing has emerged as ...
As antibody-drug conjugates (ADCs) transition from a promising therapeutic modality to a cornerstone of precision oncolo...
Viking Therapeutics has initiated a Phase 1 clinical study of VK3019, an investigational dual amylin and calcitonin rece...
UniXell Biotechnology has received U.S. FDA Investigational New Drug clearance for UX-DA003, its allogeneic induced plur...
Agilent Technologies Inc. has announced the launch of Agilent xCELLigence RTCA eSight AI, a new AI-powered software modu...
US-based Waters Corporation and IMU Biosciences, a UK-based biotechnology startup, have announced a strategic partnershi...
NeuroSense Therapeutics has reported positive biomarker findings from its Phase 2 RoAD proof-of-concept study of PrimeC ...
Cryoport’s IntegriCell cryopreservation services have been selected by Verismo Therapeutics to support the company...
Servier has enrolled the first U.S. patient in a Phase Ib/II first-in-human clinical study evaluating an investigational...
Thermo Fisher Scientific has launched the Thermo Scientific™ LabLink™ 360 Qual...
Ollin Biosciences has completed an oversubscribed US$330 million Series B financing to advance global Phase III developm...
CeleCor Therapeutics has completed submission of its New Drug Application to the U.S. FDA for zalunfiban, its investigat...
Research institutions generate groundbreaking discoveries every year, yet only a small fraction successfully reach patie...
Despite causing millions of serious infections and hundreds of thousands of deaths each year, fungal diseases continue t...
Cincinnati's life sciences ecosystem is gaining momentum through a unique combination of scientific excellence, collabor...
Oklahoma City's life sciences ambitions are increasingly centred on advanced manufacturing, collaboration, and long-term...
During BIO 2026 in San Diego, BioSpectrum Asia spoke with Kurt Imhof, Senior Vice President, Policy & Public Affairs...
During the BIO International Convention 2026 (June 22–25) in San Diego, BioSpectrum Asia spoke with Arthur Jackson...
During the BIO International Convention 2026 (June 22–25) in San Diego, BioSpectrum Asia spoke with Lan Nguyen, Ch...
